Windlas Biotech Limited has intimated changes to its Board composition through a regulatory filing dated October 12, 2026, made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Appointments

The Board of Directors, via resolution dated October 12, 2026, approved the following appointments based on the recommendation of the Nomination & Remuneration Committee:

  • Mr. Aashish Mehra (DIN: 03142813) has been appointed as an Additional Director/Independent Director effective October 12, 2026, for a period of five consecutive years, subject to shareholder approval. Mr. Mehra holds a B.Tech. Degree in Manufacturing Science and Engineering from IIT, Delhi and a P.G. Diploma in Computer-Aided Management from IIM, Calcutta. He brings over two decades of strategy, consulting and business leadership experience, with deep exposure to the pharmaceutical and life sciences industry. He is not debarred from holding the office of director by virtue of any SEBI order or other authority.
  • Mr. Soni Saran Singh (DIN: 01125022) has been appointed as an Additional Director/Independent Director effective October 12, 2026, for a period of five consecutive years, subject to shareholder approval. Mr. Singh holds a B.Sc. Degree in Mechanical Engineering from The Aligarh Muslim University and a P.G. Diploma in Marketing Management from Institute of Marketing & Management, New Delhi. He is a distinguished entrepreneur and business leader with over three decades of experience in electronics manufacturing and technology sectors, serving as Founder, Managing Director & CEO of NMTronics India Pvt. Limited and its affiliated entities across India, Singapore, and the UAE. He is not debarred from holding the office of director by virtue of any SEBI order or other authority.

Board Resignation

  • Mr. Vivek Dhariwal (DIN: 02826679) has tendered his resignation as Independent Director of the Company, effective from close of business hours on October 12, 2026, citing personal reasons and prior commitments. He confirmed there are no material reasons for his resignation other than those stated. Consequently, he has ceased to be the Chairman of the Board and Member of the Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Company.